| Primary |
| Conjunctivitis |
16.9% |
| Prostatitis |
10.8% |
| Local Anaesthesia |
9.2% |
| Tuberculosis |
7.7% |
| Cataract Operation |
6.2% |
| Drug Use For Unknown Indication |
6.2% |
| Eye Infection |
6.2% |
| Eye Operation |
4.6% |
| Pyrexia |
4.6% |
| Diarrhoea |
3.1% |
| Eye Inflammation |
3.1% |
| Hypertension |
3.1% |
| Infection Prophylaxis |
3.1% |
| Meningitis |
3.1% |
| Nephritic Syndrome |
3.1% |
| Postoperative Care |
3.1% |
| Acne |
1.5% |
| Anaesthesia |
1.5% |
| Bronchitis |
1.5% |
| Conjunctivitis Bacterial |
1.5% |
|
| Aplastic Anaemia |
14.3% |
| Visual Acuity Reduced |
11.4% |
| Eye Swelling |
8.6% |
| Hepatitis |
8.6% |
| Thrombocytopenia |
8.6% |
| Pancytopenia |
5.7% |
| Prostatitis |
5.7% |
| Anaphylactic Reaction |
2.9% |
| Blood Disorder |
2.9% |
| Bone Marrow Failure |
2.9% |
| Drug Interaction |
2.9% |
| Embolic Stroke |
2.9% |
| Eye Irritation |
2.9% |
| Eye Pain |
2.9% |
| Haemoptysis |
2.9% |
| Hepatitis Acute |
2.9% |
| Hypersensitivity |
2.9% |
| Myelodysplastic Syndrome |
2.9% |
| Non-infectious Endophthalmitis |
2.9% |
| Ocular Hyperaemia |
2.9% |
|
| Secondary |
| Preoperative Care |
17.7% |
| Product Used For Unknown Indication |
12.4% |
| Anaesthesia |
9.5% |
| Postoperative Care |
9.5% |
| Cataract Operation |
7.2% |
| Drug Use For Unknown Indication |
7.0% |
| Antibiotic Prophylaxis |
5.5% |
| Local Anaesthesia |
4.0% |
| Prophylaxis |
3.2% |
| Pseudomonas Infection |
3.0% |
| Diarrhoea |
2.5% |
| Hypertension |
2.5% |
| Keratitis |
2.5% |
| Uveitis |
2.5% |
| Lymphocytic Leukaemia |
2.2% |
| Corneal Abrasion |
2.0% |
| Joint Injury |
2.0% |
| Ocular Hyperaemia |
2.0% |
| Post Procedural Complication |
1.5% |
| Pyrexia |
1.5% |
|
| Visual Acuity Reduced |
23.1% |
| Endophthalmitis |
15.4% |
| Toxic Anterior Segment Syndrome |
10.3% |
| Anaemia |
5.1% |
| Parophthalmia |
5.1% |
| Thrombocytopenia |
5.1% |
| Dizziness |
3.8% |
| Hepatitis |
3.8% |
| Ulcerative Keratitis |
3.8% |
| Corneal Oedema |
2.6% |
| Intraocular Pressure Increased |
2.6% |
| Mucoepidermoid Carcinoma |
2.6% |
| Ocular Toxicity |
2.6% |
| Post Procedural Complication |
2.6% |
| Sepsis |
2.6% |
| Small For Dates Baby |
2.6% |
| Staphylococcal Infection |
2.6% |
| Anterior Chamber Disorder |
1.3% |
| Aplasia Pure Red Cell |
1.3% |
| Aplastic Anaemia |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.2% |
| Drug Use For Unknown Indication |
24.7% |
| Diffuse Large B-cell Lymphoma |
5.7% |
| Hypertension |
4.1% |
| Prophylaxis |
3.9% |
| Rheumatoid Arthritis |
3.7% |
| Ill-defined Disorder |
3.2% |
| Retinal Haemorrhage |
2.2% |
| Epilepsy |
2.0% |
| Hepatic Neoplasm Malignant |
2.0% |
| Constipation |
1.9% |
| Diarrhoea |
1.7% |
| Infection |
1.7% |
| Nausea |
1.6% |
| Local Anaesthesia |
1.5% |
| Oesophageal Carcinoma |
1.3% |
| Rash |
1.3% |
| Drug Exposure During Pregnancy |
1.2% |
| Cough |
1.1% |
| Eye Infection |
1.1% |
|
| Premature Labour |
15.8% |
| Visual Acuity Reduced |
11.0% |
| Sepsis |
6.8% |
| Vomiting |
6.2% |
| Pyrexia |
5.5% |
| Intraocular Pressure Increased |
4.8% |
| Rash |
4.1% |
| Tachycardia |
4.1% |
| Thrombocytopenia |
4.1% |
| Toxic Anterior Segment Syndrome |
4.1% |
| Ventricular Septal Defect |
4.1% |
| Hepatitis |
3.4% |
| Hyponatraemia |
3.4% |
| Keratopathy |
3.4% |
| Pernicious Anaemia |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Syncope |
3.4% |
| Urinary Tract Infection |
3.4% |
| Death |
2.7% |
| Gastric Perforation |
2.7% |
|
| Interacting |
| Cns Ventriculitis |
26.7% |
| Aspergillosis |
13.3% |
| Ependymitis |
13.3% |
| Fungus Serology Test |
13.3% |
| Product Used For Unknown Indication |
13.3% |
| Atrial Fibrillation |
6.7% |
| Convulsion |
6.7% |
| Drug Use For Unknown Indication |
6.7% |
|
| Potentiating Drug Interaction |
40.0% |
| Grand Mal Convulsion |
20.0% |
| Hypersensitivity |
20.0% |
| Visual Acuity Reduced |
20.0% |
|
